PC and Hepatic fibrosis: Following repeated injections of CCl4, the serum concentrations of four indices of liver fibrosis, PC-III, COL-IV, HA, and LN, and liver injury indices, AST and ALT viability, were markedly increased, whereas the administration of SCU substantially reduced the serum levels of PC-III, COL-IV, HA, and LN alongside the dose-dependent efficacy of AST and ALT (Figure 1E–J).